Molecular formula: | C28H50N4O7 |
Average mass: | 554.729 |
Monoisotopic mass: | 554.367950 |
ChemSpider ID: | 9401737 |
8 of 8 defined stereocentres
134381-21-8
[RN]Epoxomicin
L-Threoninamide, N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-
[ACD/Index Name]MFCD03791061
[MDL number]N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-L-threoninamide
N-Acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-1-oxo-2-pentanyl}-L-threoninamid
[German]
[ACD/IUPAC Name]N-Acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-1-oxo-2-pentanyl}-L-threoninamide
[ACD/IUPAC Name]N-Acétyl-N-méthyl-L-isoleucyl-L-isoleucyl-N-{(2S)-4-méthyl-1-[(2R)-2-méthyl-2-oxiranyl]-1-oxo-2-pentanyl}-L-thréoninamide
[French]
[ACD/IUPAC Name]Y0900I3U8U
[UNII](2R,3S)-2-[acetyl(methyl)amino]-N-[(2S,3S)-1-{[(2S,3R)-3-hydroxy-1-({(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}amino)-1-oxobutan-2-yl]amino}-3-methyl-1-oxopentan-2-yl]-3-methylpentanamide
(2S,3S)-2-[[(2S,3S)-2-(acetyl-methyl-amino)-3-methyl-pentanoyl]amino]-N-[(1S,2R)-2-hydroxy-1-[[(1S)-3-methyl-1-[(2R)-2-methyloxirane-2-carbonyl]butyl]carbamoyl]propyl]-3-methyl-pentanamide
(2S,3S)-2-[[(2S,3S)-2-(acetyl-methylamino)-3-methyl-1-oxopentyl]amino]-N-[(1S,2R)-2-hydroxy-1-[[[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]-oxomethyl]butyl]amino]-oxomethyl]propyl]-3-methylpentanamide(2S,3S)-2-[[(2S,3S)-2-(acetyl-methyl-amino)-3-methyl-pentanoyl]amino]-N-[(1S,2R)-2-hydroxy-1-[[(1S)-3-methyl-1-[(2R)-2-methyloxirane-2-carbonyl]butyl]carbamoyl]propyl]-3-methyl-valeramide
(2S,3S)-2-[[(2S,3S)-2-(acetyl-methylamino)-3-methylpentanoyl]amino]-N-[(2S,3R)-3-hydroxy-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxobutan-2-yl]-3-methylpentanamide
(2S,3S)-2-[[(2S,3S)-2-(ethanoyl-methyl-amino)-3-methyl-pentanoyl]amino]-N-[(2S,3R)-3-hydroxy-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-pentan-2-yl]amino]-1-oxo-butan-2-yl]-3-methyl-pentanamideBU-4061T
(2S,3S)-2-[[(2S,3S)-2-[acetyl(methyl)amino]-3-methylpentanoyl]amino]-N-[(2S,3R)-3-hydroxy-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxobutan-2-yl]-3-methylpentanamide
(2S,3S)-N-((2S,3R)-3-Hydroxy-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxobutan-2-yl)-3-methyl-2-((2S,3S)-3-methyl-2-(N-methylacetamido)pentanamido)pentanamide
(2S,3S)-N-[(1S,2R)-2-hydroxy-1-{[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]carbamoyl}propyl]-3-methyl-2-[(2S,3S)-3-methyl-2-(N-methylacetamido)pentanamido]pentanamide
95%
BU-4061T
epoxomycin
E′epoxomicin′
L-Threoninamide,N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-
N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-threoninamide
β-secretaseinhibitor2